Article

DC briefing boosts collaborative effort

Washington, DC-A congressional briefing held recently at the National Eye Institute (NEI) of the National Institutes of Health has highlighted the need for research partnerships to fight diabetic retinopathy effectively.

Washington, DC-A congressional briefing held recently at the National Eye Institute (NEI) of the National Institutes of Health has highlighted the need for research partnerships to fight diabetic retinopathy effectively.

The briefing featured Thomas W. Gardner, MD, MS, a diabetes researcher, clinician, and professor of ophthalmology and cellular and molecular physiology at the Pennsylvania State University Milton S. Hershey Medical Center, part of the Diabetic Retinopathy Clinical Research Network.

During the 1-day event, Dr. Gardner met with Rep. Gene Green (D-TX), a co-chairman of the Congressional Vision Caucus with NIH oversight, as well as senators Arlen Specter and Rick Santorum (both R-PA).

The network includes 545 experts at 163 clinical sites in 43 states and is one of several collaborative efforts funded by the NEI over the past 30 years to study diabetic retinopathy.

These networks have led to effective diabetic retinopathy treatments that have reduced blindness by 90% and saved $1.6 billion annually in health-care costs, the NEI said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.